-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on IO Biotech (IOBT), PT $8, 'A positive PFS could also provide sig upside potential'
-
-
-
-
-
-
-
IO Biotech Announces 2023 Third Quarter Results
-
-
-
-
-
-
-
IO Biotech Announces First Quarter Results for 2022
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

